BMG Pharma – a biotech and B2B company headquartered in Milan with its chemical plant in Torviscosa (Italy) that exports its medical products to more than 80 countries – has signed a development and commercial agreement with HTL, a leading biotech and industrial player in the development and production of innovative, pharmaceutical-grade biopolymers. With this […]
The post BMG Pharma and HTL sign a development agreement to manufacture BMG’s new biopolymer based on the Hyaluromimethic Technology first appeared on World Pharma Today.This post first appeared on Leading Pharmaceutical Industry Online Platform, please read the originial post: here